Carotid stenting Carotid stenting Carotid artery stenting (CAS) is an endovascular procedure where a stent is deployed within the lumen of the carotid artery to treat narrowing of the carotid artery and decrease the risk of stroke. CAS is used to treat narrowing of the carotid artery in high-risk patients, when carotid endarterectomy is considered too risky. Carotid artery stenosis can present with no symptoms or with symptoms such as transient ischemic attacks (TIAs) or strokes. The largest clinical trial to date, CREST, compared stenting to surgery on the collective incidence of any stroke, any heart attack or death. They found that
Carotid body body is sent to the cardiorespiratory centers in the medulla oblongata via the afferent branches of the glossopharyngeal nerve. The afferent fibres of the aortic body chemoreceptors are relayed by the vagus nerve. These centers, in turn, regulate breathing and blood pressure, with hypoxia causing an increase in ventilation. A paraganglioma is a tumor that may involve the carotid body and is usually benign. Rarely, a malignant neuroblastoma may originate from the carotid body. Innervated by glossopharyngeal nerve (cranial nerve IX). Carotid body The carotid body ("carotid glomus" or "glomus caroticum") is a small cluster of chemoreceptors and supporting cells